ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

ASCO Honors Eight With Special Awards

May 24, 2002

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981

DCBDC Advisors Set aside $2 Mil. For Research On The Microenvironment of Breast Cancer

July 9, 1993

New Research Projects Proposed For Immunology

September 30, 1977

NCI Agrees To Offer New Screening RFP In The Future

May 28, 1976

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002